M. Henry

Researcher

UAMS

Also affiliated: Argonne National Laboratory (2024); Michael E. DeBakey VA Medical Center (2014); DuPont (United States) (1989–1990); Plant & Food Research (2005); UF Health Shands Hospital (2023); Baylor College of Medicine (2014); University of Ibadan (2018); Medical College of Wisconsin (2023); University of Michigan (2015); North Shore University Hospital (1972); Health Protection Scotland (2006–2007); Nassau University Medical Center (1972); North Shore Hospital (1972); Cork University Hospital (1998); University of Florida (2022–2023); St Francis’ Hospital (2019); St. Francis Hospital (2019–2025); Office of the Chief Scientist (1972); Experimental Station (1990); Cook Research (United States) (2002); Elanco (United States) (1992); St Francis Chronic Hospital (2019); Dow Chemical (United States) (2002); Hôpital Raymond-Poincaré (2007); St. Luke's Hospital (2014); Hôpital Jeanne d'Arc (1972–1978); St. Francis Referral Hospital (2019); Naggalama Hospital (2019); Marymount University (1973); The University of Texas Medical Branch at Galveston (1967); University of Maryland, College Park (1979–1990); University of Otago (2005); Florida College (2022–2023)

Faculty Researcher

16 h-index 90 pubs 1,056 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

M. Henry's research focuses on cardiovascular disease and its treatment, particularly in the context of structural heart conditions. Recent publications investigate transcatheter aortic valve replacement outcomes comparing different valve types, as well as the etiologies and exclusion rates in transcatheter mitral and tricuspid valve structural heart clinical trials. The researcher also has work related to pediatric point-of-care ultrasound and prognostic tools for predicting brain death following out-of-hospital cardiac arrest in children. Other research areas include the detection of SARS-CoV-2 antibodies in human milk and the role of CMV promoter methylation in cell productivity for recombinant monoclonal antibodies. Henry holds an h-index of 16, with 90 total publications and over 1,000 citations.

Metrics

h-index: 16
Publications: 90
Citations: 1,056

Selected Publications

Study protocol for a pilot study for Remote ADHD Monitoring Program (RAMP) for children in rural areas (2025)

PLoS ONE DOI OpenAlex
The protocol for a pilot feasibility trial of Improving Neurodevelopmental ouTcomes After prenatal Cannabinoid in uTero exposure (INTACT) study for a multi-center trial (2025)

PLoS ONE DOI OpenAlex
Real-world comparative outcomes of EGFR-TKIs for first-line treatment of EGFR+ metastatic non–small-cell lung cancer (2025)

Cancer Treatment and Research Communications DOI OpenAlex
Real-World Comparative Outcomes of Egfr-Tkis for First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (2024)

SSRN Electronic Journal DOI OpenAlex
Characterization of the Immune Impact of Daratumumab By Mass Cytometry in Multiple Myeloma (2018)

Blood 1 citation DOI OpenAlex
Expression Signature of Myeloma Residual Cells Is Characterized By Genes Associated with Proliferation, Epigenetic Modification, and Stem Cell Maintenance (2018)

Blood 1 citation DOI OpenAlex